- Home
- GXAI vs FOXO Comparison
GXAI vs FOXO Comparison
Compare GXAI & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GXAI
- FOXO
- Stock Information
- Founded
- GXAI 2021
- FOXO 2019
- Country
- GXAI United States
- FOXO United States
- Employees
- GXAI N/A
- FOXO N/A
- Industry
- GXAI
- FOXO Retail: Computer Software & Peripheral Equipment
- Sector
- GXAI
- FOXO Technology
- Exchange
- GXAI Nasdaq
- FOXO Nasdaq
- Market Cap
- GXAI 7.5M
- FOXO 8.0M
- IPO Year
- GXAI 2023
- FOXO N/A
- Fundamental
- Price
- GXAI $3.34
- FOXO $0.34
- Analyst Decision
- GXAI
- FOXO
- Analyst Count
- GXAI 0
- FOXO 0
- Target Price
- GXAI N/A
- FOXO N/A
- AVG Volume (30 Days)
- GXAI 17.6M
- FOXO 9.5M
- Earning Date
- GXAI 11-14-2024
- FOXO 11-19-2024
- Dividend Yield
- GXAI N/A
- FOXO N/A
- EPS Growth
- GXAI N/A
- FOXO N/A
- EPS
- GXAI N/A
- FOXO N/A
- Revenue
- GXAI $2,979.00
- FOXO $1,341,000.00
- Revenue This Year
- GXAI N/A
- FOXO N/A
- Revenue Next Year
- GXAI N/A
- FOXO N/A
- P/E Ratio
- GXAI N/A
- FOXO N/A
- Revenue Growth
- GXAI N/A
- FOXO 196.03
- 52 Week Low
- GXAI $1.01
- FOXO $0.13
- 52 Week High
- GXAI $19.20
- FOXO $1.30
- Technical
- Relative Strength Index (RSI)
- GXAI 60.25
- FOXO 41.26
- Support Level
- GXAI $2.69
- FOXO $0.35
- Resistance Level
- GXAI $4.41
- FOXO $0.53
- Average True Range (ATR)
- GXAI 1.08
- FOXO 0.06
- MACD
- GXAI 0.11
- FOXO -0.03
- Stochastic Oscillator
- GXAI 37.80
- FOXO 1.88
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.
About FOXO FOXO Technologies Inc.
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.